DrugCard: AI-Powered Local Literature Screening for Pharma

DrugCard is an AI-enabled solution designed to streamline drug safety routines and ensure regulatory compliance within the pharmaceutical industry. It offers continuous, regular screening of local market literature, providing crucial up-to-date information.

Features

• AI-powered screening: Automatically scans and analyzes medical literature from over 35 countries and in over 100 languages.
• Comprehensive coverage: Accesses medical journals globally, ensuring extensive literature review.
• High accuracy: Boasts a high accuracy rate, particularly in scanned PDF screening.
• Scalability and flexibility: Easily adapts to new markets and supports multiple languages and suppliers.
• Traceability and transparency: Provides a clear audit trail of the entire screening process.
• Cost-effective: Requires minimal capital investment, making it accessible to various organizations.

Benefits

• Improved efficiency: Automates time-consuming tasks, freeing up valuable time for other activities.
• Enhanced compliance: Helps meet regulatory requirements and mitigate risks.
• Reduced costs: Low capital investment and improved efficiency lead to significant cost savings.
• Increased accuracy: Minimizes human error and ensures comprehensive literature review.
• Global reach: Allows for seamless expansion into new international markets.

Use Cases

• Contract Research Organizations (CROs): Manage more projects and improve screening results.
• Marketing Authorization Holders (MAHs): Perform in-house screening to mitigate compliance and reputation risks.
• Freelancers: Save time on literature screening and focus on higher-value tasks.

DrugCard offers a reliable and efficient solution for local literature screening, empowering pharmaceutical companies to optimize their drug safety processes and maintain regulatory compliance.